Transversalis Fascia Plane Block for Iliac Bone Graft in Children

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · May 3, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring the best way to manage pain after surgery in children who are having a specific type of bone grafting procedure called iliac bone grafting for alveoloplasty. The researchers are comparing two methods of pain control: one uses an ultrasound-guided technique to block nerves in the abdomen, and the other focuses on the transversalis fascia, a layer of tissue in the same area. The goal is to find out which method works better for reducing pain after surgery.

To be eligible for this study, children must be between 7 and 17 years old and scheduled for this bone grafting procedure. However, some children may not be able to participate if they have certain medical conditions that affect how they feel pain, have trouble communicating, or have unstable vital signs. Participants will receive one of the pain control methods during their surgery, and researchers will monitor how well it works. This trial is currently recruiting participants, and it aims to help improve pain management for children undergoing this type of surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children aged 7 years and older but under 18 undergoing iliac bone grafting for alveoloplasty
• Exclusion Criteria:
• • Patients with diseases that affect pain sensitivity differently from the general population (e.g., congenital insensitivity to pain with anhidrosis, complex regional pain syndrome, etc.)
• • Cases where there is difficulty in expressing pain (due to cognitive or functional deficits, or limited ability to communicate)
• • Unstable vital signs (heart rate, blood pressure)
• • Common contraindications for Ropivacaine: 1) Patients with a history of hypersensitivity to this drug or other amide local anesthetics, 2) Patients in a state of major bleeding or shock, 3) Patients with inflammation at or around the site of administration, 4) Patients with sepsis, 5) Intravenous regional anesthesia (Bier block)
• • History of allergy to opioid medications
• • Severe renal impairment (Creatinine \>3.0mg/dL)
• • Severe liver function abnormalities (aspartate transaminase \> 120 unit/L, alanine aminotransferase \> 120 unit/L)
• • Peripheral nervous system disorders
• • Other cases deemed unsuitable by the researcher